Cargando…

Risk stratification for prediction of locoregional recurrence in patients with pathologic T1–2N0 breast cancer after mastectomy

BACKGROUND: Previous studies have revealed that nearly 15–20% of selected high-risk T1–2N0 breast cancers developed LRR after mastectomy. This study is aim to indentify the risk factors of locoregional recurrence (LRR) in patients with pathologic T1–2N0 breast cancer after mastectomy in a real-world...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jianyang, Tang, Yu, Jing, Hao, Sun, Guangyi, Jin, Jing, Liu, Yueping, Song, Yongwen, Wang, Weihu, Fang, Hui, Chen, Bo, Qi, Shunan, Ren, Hua, Li, Ning, Tang, Yuan, Lu, Ningning, Yang, Yong, Yu, Zihao, Wang, Shulian, Li, Yexiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685539/ https://www.ncbi.nlm.nih.gov/pubmed/33228588 http://dx.doi.org/10.1186/s12885-020-07594-7

Ejemplares similares

Locoregional recurrence patterns in women with breast cancer who have not undergone post-mastectomy radiotherapy
por: Zhao, Xuran, et al.
Publicado: (2020)

Postoperative intensity-modulated radiation therapy provides favorable local control and low toxicities in patients with soft tissue sarcomas in the extremities and trunk wall
por: Wang, Jianyang, et al.
Publicado: (2015)

Comparison of outcome and toxicity of postoperative intensity‐modulated radiation therapy with two‐dimensional radiotherapy in patients with soft tissue sarcoma of extremities and trunk
por: Wang, Jianyang, et al.
Publicado: (2019)

Effectiveness of the AJCC 8th edition staging system for selecting patients with T1–2N1 breast cancer for post-mastectomy radiotherapy: a joint analysis of 1986 patients from two institutions
por: Wang, Shulian, et al.
Publicado: (2020)

Inter‐ and intrafractional setup errors and baseline shifts of fiducial markers in patients with liver tumors receiving free‐breathing postoperative radiation analyzed by cone‐beam computed tomography
por: Zhang, Tao, et al.
Publicado: (2014)

Prospective evaluation of microscopic extension using whole-mount preparation in patients with hepatocellular carcinoma: Definition of clinical target volume for radiotherapy
por: Wang, Weihu, et al.
Publicado: (2010)

Circulating serum microRNA-345 correlates with unfavorable pathological response to preoperative chemoradiotherapy in locally advanced rectal cancer
por: Yu, Jing, et al.
Publicado: (2016)

Long-term outcomes of moderately hypofractionated radiotherapy (67.5 Gy in 25 fractions) for prostate cancer confined to the pelvis: a single center retrospective analysis
por: Yao, Lihong, et al.
Publicado: (2020)

A Phase II prospective nonrandomized trial of magnetic resonance imaging-guided hematopoietic bone marrow-sparing radiotherapy for gastric cancer patients with concurrent chemotherapy
por: Wang, Jianyang, et al.
Publicado: (2016)

Assessment and validation of the internal gross tumour volume of gastroesophageal junction cancer during simultaneous integrated boost radiotherapy
por: Shi, Jinming, et al.
Publicado: (2022)

Adjuvant Chemoradiotherapy Versus Adjuvant Chemotherapy for Stage III Gastric or Gastroesophageal Junction Cancer After D2/R0 Resection
por: Shi, Jinming, et al.
Publicado: (2022)

Development and Validation of an MRI-Based Nomogram Model for Predicting Disease-Free Survival in Locally Advanced Rectal Cancer Treated With Neoadjuvant Radiotherapy
por: Chen, Silin, et al.
Publicado: (2021)

Down-staging depth score could be a survival predictor for locally advanced gastric cancer patients after preoperative chemoradiotherapy
por: Li, Ning, et al.
Publicado: (2021)

Associations of Genetic Variations in Mismatch Repair Genes MSH3 and PMS1 with Acute Adverse Events and Survival in Patients with Rectal Cancer Receiving Postoperative Chemoradiotherapy
por: Yang, Jie, et al.
Publicado: (2019)

Preoperative versus postoperative chemo-radiotherapy for locally advanced gastric cancer: a multicenter propensity score-matched analysis
por: Li, Ning, et al.
Publicado: (2022)

Total neoadjuvant therapy for locally advanced gastric cancer and esophagogastric junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase II clinical trial
por: Shi, Jinming, et al.
Publicado: (2022)

Genetic polymorphisms in genes regulating cell death and prognosis of patients with rectal cancer receiving postoperative chemoradiotherapy
por: Chen, Hongxia, et al.
Publicado: (2023)

MiR‐320b/RAD21 axis affects hepatocellular carcinoma radiosensitivity to ionizing radiation treatment through DNA damage repair signaling
por: Wang, Jianyang, et al.
Publicado: (2020)

A prospective phase I study of hypo-fractionated neoadjuvant radiotherapy for locally advanced gastric cancer
por: Li, Ning, et al.
Publicado: (2018)

Response prediction and risk stratification of patients with rectal cancer after neoadjuvant therapy through an analysis of circulating tumour DNA
por: Liu, Wenyang, et al.
Publicado: (2022)

Radiomics Analysis of Fat-Saturated T2-Weighted MRI Sequences for the Prediction of Prognosis in Soft Tissue Sarcoma of the Extremities and Trunk Treated With Neoadjuvant Radiotherapy
por: Chen, Silin, et al.
Publicado: (2021)

Impact of clinical-pathological factors on locoregional recurrence in mastectomy patients with T1-2N1 breast cancer: who can omit adjuvant radiotherapy?
por: Wang, Xiaofang, et al.
Publicado: (2021)

An Eighteen-Gene Classifier Predicts Locoregional Recurrence in Post-Mastectomy Breast Cancer Patients
por: Cheng, Skye H., et al.
Publicado: (2016)

Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy
por: Dominici, Laura S, et al.
Publicado: (2012)

Treatment results of breast cancer patients with locoregional recurrence after mastectomy
por: Jeong, Yuri, et al.
Publicado: (2013)

Prognostic Factors for Distant Metastasis in Patients with Locoregional Recurrence after Mastectomy
por: Jeong, Yuri, et al.
Publicado: (2015)

Development and external validation of a nomogram to predict four or more positive nodes in breast cancer patients with one to three positive sentinel lymph nodes
por: Yang, Zhuanbo, et al.
Publicado: (2020)

CNN-Based Quality Assurance for Automatic Segmentation of Breast Cancer in Radiotherapy
por: Chen, Xinyuan, et al.
Publicado: (2020)

Isolated locoregional recurrence patterns of breast cancer after mastectomy and adjuvant systemic therapies in the contemporary era
por: Ma, Jinli, et al.
Publicado: (2015)

Outcomes Following Salvage Radiation and Systemic Therapy for Isolated Locoregional Recurrence of Breast Cancer after Mastectomy: Impact of Constructed Biologic Subtype
por: Wang, Xiaofang, et al.
Publicado: (2018)

Predicting pathological complete response of neoadjuvant radiotherapy and targeted therapy for soft tissue sarcoma by whole-tumor texture analysis of multisequence MRI imaging
por: Miao, Lei, et al.
Publicado: (2022)

The location of locoregional recurrence in pathologic T3N0, non-irradiated lower rectal cancer
por: Kim, Mi Sun, et al.
Publicado: (2013)

Data on distant metastasis and survival after locoregional recurrence following nipple-sparing mastectomy and immediate breast reconstruction
por: Wu, Zhen-Yu, et al.
Publicado: (2021)

Prognostic validation and therapeutic decision‐making of the AJCC eighth pathological prognostic staging for T3N0 breast cancer after mastectomy
por: Wu, San‐Gang, et al.
Publicado: (2020)

Sequencing chemotherapy and radiotherapy in locoregional advanced breast cancer patients after mastectomy – a retrospective analysis
por: Piroth, Marc D, et al.
Publicado: (2008)

Comparison of Locoregional Recurrence with Mastectomy vs. Breast Conserving Surgery in Pregnancy Associated Breast Cancer (PABC)
por: Beriwal, Sushil, et al.
Publicado: (2009)

Locoregional Outcomes in Clinical Stage IIB Breast Cancer After Neoadjuvant Therapy and Mastectomy With or Without Radiation
por: Diaz, Dayssy A., et al.
Publicado: (2014)

Factors Predicting Locoregional Recurrence After Neoadjuvant Chemotherapy and Nipple-Sparing/Skin-Sparing Mastectomy With Immediate Breast Reconstruction
por: Wu, Zhen-Yu, et al.
Publicado: (2021)

Pathological Responses of the Primary Tumor and Locoregional Lymph Nodes After Neoadjuvant Immunochemotherapy in Esophageal Squamous Cell Cancer
por: Huang, Shu Jie, et al.
Publicado: (2022)

Postmastectomy radiotherapy reduces locoregional and disease recurrence in patients with stage II–III triple-negative breast cancer treated with neoadjuvant chemotherapy and mastectomy
por: Chen, Xingxing, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5bi61bh6cqf2auh83c012hafh3